Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hakkarainen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nanotechnology|August 10, 2011
Transformation of InAs islands to quantum ring structures by metalorganic vapor phase epitaxyA Aierken, T Hakkarainen, J Riikonen, et al.
Histochemistry and Cell Biology|February 24, 2001
Green fluorescent protein (GFP) fusion constructs in gene therapy researchJ Wahlfors, S Loimas, T Pasanen, et al.
Nanotechnology|November 13, 2015
Crystal-structure-dependent photoluminescence from InP nanowiresM Mattila, T Hakkarainen, M Mulot, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|February 12, 2014
The impact of surgical wound bacterial colonization on the incidence of surgical site infection after lower limb vascular surgery: a prospective observational studyJ Turtiainen, T Hakala, T Hakkarainen, et al.
Respiratory Medicine|March 1, 1991
Unilateral bronchiolitis obliterans organizing pneumonia and bronchoalveolar lavage neutrophilia in a patient with parainfluenza 3 virus infectionE Perämäki, I Salmi, T Kava, et al.
Gene Therapy|July 6, 2007
Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirusM Raki, T Hakkarainen, G J Bauerschmitz, et al.
Gene Therapy|April 11, 2008
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodiesM Särkioja, S Pesonen, M Raki, et al.
Gene Therapy|May 15, 2009
Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatmentK Guse, I Diaconu, M Rajecki, et al.
Radiology|June 1, 1994
Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-upP J Matsi, H I Manninen, R L Vanninen, et al.
Gene Therapy|April 15, 2011
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cellsJ Leja, D Yu, B Nilsson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nanotechnology|August 10, 2011
Transformation of InAs islands to quantum ring structures by metalorganic vapor phase epitaxyA Aierken, T Hakkarainen, J Riikonen, et al.
Histochemistry and Cell Biology|February 24, 2001
Green fluorescent protein (GFP) fusion constructs in gene therapy researchJ Wahlfors, S Loimas, T Pasanen, et al.
Nanotechnology|November 13, 2015
Crystal-structure-dependent photoluminescence from InP nanowiresM Mattila, T Hakkarainen, M Mulot, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|February 12, 2014
The impact of surgical wound bacterial colonization on the incidence of surgical site infection after lower limb vascular surgery: a prospective observational studyJ Turtiainen, T Hakala, T Hakkarainen, et al.
Respiratory Medicine|March 1, 1991
Unilateral bronchiolitis obliterans organizing pneumonia and bronchoalveolar lavage neutrophilia in a patient with parainfluenza 3 virus infectionE Perämäki, I Salmi, T Kava, et al.
Gene Therapy|July 6, 2007
Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirusM Raki, T Hakkarainen, G J Bauerschmitz, et al.
Gene Therapy|April 11, 2008
Changing the adenovirus fiber for retaining gene delivery efficacy in the presence of neutralizing antibodiesM Särkioja, S Pesonen, M Raki, et al.
Gene Therapy|May 15, 2009
Ad5/3-9HIF-Delta24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatmentK Guse, I Diaconu, M Rajecki, et al.
Radiology|June 1, 1994
Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-upP J Matsi, H I Manninen, R L Vanninen, et al.
Gene Therapy|April 15, 2011
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cellsJ Leja, D Yu, B Nilsson, et al.
Pageof 2